{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:33:26Z","timestamp":1760297606664},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,4,30]],"date-time":"2006-04-30T00:00:00Z","timestamp":1146355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title><jats:styled-content>Objectives<\/jats:styled-content>:<\/jats:title><jats:p>Our study aimed to compare the isosmolar nonionic dimer iodixanol and the low osmolar ionic agent ioxaglate in the current era of percutaneous coronary intervention (PCI), using clopidogrel, enoxaparine, direct stenting, and drug eluting stent.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:styled-content>Background<\/jats:styled-content>:<\/jats:title><jats:p>Previous studies have suggested an association between thrombus\u2010related events and type of contrast media.\u2003<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:styled-content>Methods<\/jats:styled-content>:<\/jats:title><jats:p>Our prospective single\u2010center study included 498 consecutive patients who were assigned to receive either iodixanol (<jats:italic>n<\/jats:italic> = 231) or ioxaglate (<jats:italic>n<\/jats:italic> = 267). The primary endpoint was the cumulative rate of in\u2010hospital major adverse clinical events (MACE). A secondary endpoint was the rate of angiographic or procedural complications.\u2003<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:styled-content>Results<\/jats:styled-content>:<\/jats:title><jats:p>Clinical and angiographic baseline characteristics and procedural data were similar in the 2 groups. A peak anti\u2010Xa &gt;0.5 IU\/ml was obtained in 97% in both groups. Glycoprotein IIb\/IIIa inhibitors were used in 42% of patients. Coronary stenting was performed in 91% of patients, with direct stenting in 70%, and drug\u2010eluting stent in 28% of patients. In\u2010hospital MACE was more frequent in patients receiving iodixanol compared with those receiving ioxaglate (4.8% vs. 0.3%, <jats:italic>P<\/jats:italic> &lt; 0.005). This difference was mainly related to the appearance of a large thrombus during PCI (6% with iodixanol vs. 0.3% with ioxaglate, <jats:italic>P<\/jats:italic> &lt; 0.0001). In multivariate analysis, independent predictors of in\u2010hospital MACE were use of iodixanol (<jats:italic>P<\/jats:italic> &lt; 0.01), the higher number of stent used (<jats:italic>P<\/jats:italic> &lt; 0.008), bifurcation\/ostial lesion (<jats:italic>P<\/jats:italic> &lt; 0.01), and balloon dilation before stenting (p &lt; 0.001).\u2003<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:styled-content>Conclusions<\/jats:styled-content>:<\/jats:title><jats:p>In our study reflecting the current era of PCI, thrombus\u2010related events are more frequent with the isosmolar nonionic dimer iodixanol than with the low osmolar ionic agent ioxaglate. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.20670","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T02:51:57Z","timestamp":1146451917000},"page":"852-858","source":"Crossref","is-referenced-by-count":17,"title":["Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty"],"prefix":"10.1002","volume":"67","author":[{"given":"Claude","family":"Le Feuvre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Batisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean P.","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean P","family":"Batisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my","family":"Choussat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Helft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean P","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-198501002-00017"},{"key":"e_1_2_6_3_2","first-page":"4","article-title":"Iopamidol use in the cardiac catheterization laboratory: A retrospective analysis of 3312 patients","volume":"5","author":"Bashore TM","year":"1985","journal-title":"Cardiology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-198409001-00011"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.119998"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-200301000-00005"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065213"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.09.031"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199609000-00005"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01118.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2319"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00040-X"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00842-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.18.2172"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841859609175476"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00026.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.1810280203"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90489-8"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90863-G"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70074-2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00600-7"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.2.131"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10326"},{"key":"e_1_2_6_24_2","unstructured":"MontalescotG.Safety and efficacy of enoxaparin in percutaneous coronary intervention patients an international randomized evaluation. ESC Congress 2005 Stockholm Sweden Hot line Session. 5 September 2005."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.5.658"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10726"},{"key":"e_1_2_6_27_2","first-page":"45","article-title":"Enoxaparin vs. unfractionated heparin in high\u2010risk patients with non\u2013ST\u2010segment elevation acute coronary syndromesmanaged with an intended early invasive strategy. primary results of the synergy randomized trial","volume":"292","author":"The SYNERGY Investigators","year":"2004","journal-title":"JAMA"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20352"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(03)00165-0"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02531-7"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.01.071"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/107424840501000401"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.20670","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.20670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T07:05:20Z","timestamp":1697094320000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.20670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,30]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1002\/ccd.20670"],"URL":"https:\/\/doi.org\/10.1002\/ccd.20670","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,30]]}}}